No takes yet. Share an insight, caveat, or question.
Case report details worsening heart failure in a patient with Mucopolysaccharidosis I, highlighting enzyme replacement therapy limitations and valvular disease pathology.
Juliana et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: